Rothschild Investment »

Tvardi Therapeutics shares owned by Rothschild Investment

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2026-03-31 $38 12 3.17

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Invesco Rafi Us 1000 Etf Etf (PRF)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Amazon Stock (AMZN)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Exxon Mobil Corp Stock (XOM)
Johnson & Johnson Stock (JNJ)
Capital Group Dividend Growers Etf Etf (CGDG)
Blackstone Stock (BX)
Abbvie Stock (ABBV)
Chevron Corporation Stock (CVX)

View all positions for Rothschild Investment

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
Vanguard Capital Management
American Financial Group
Geode Capital Management
State Street Corporation
Renaissance Technologies
Silvercrest Asset Management Group
Morgan Stanley
Duncan Williams Asset Management
UBS Group
Northern Trust
Vanguard Fiduciary Trust
Farallon Capital Management

View all funds holding Tvardi Therapeutics